AFMD(AFMD)
AFMD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $2M | $3M | $9M | $13M |
| Low | $2M | $3M | $9M | $13M |
| High | $2M | $3M | $9M | $13M |
| EBITDA Avg | $-2M | $-3M | $-9M | $-13M |
| Low | $-2M | $-3M | $-9M | $-13M |
| High | $-2M | $-3M | $-9M | $-13M |
| EBIT Avg | $-2M | $-3M | $-9M | $-13M |
| Low | $-2M | $-3M | $-9M | $-13M |
| High | $-2M | $-3M | $-9M | $-13M |
| Net Income Avg | $-21M | $-17M | $-16M | $-13M |
| Low | $-21M | $-17M | $-16M | $-13M |
| High | $-21M | $-17M | $-16M | $-13M |
| EPS Avg | $-1.38 | $-1.16 | $-1.05 | $-0.86 |
| Low | $-1.38 | $-1.16 | $-1.05 | $-0.86 |
| High | $-1.38 | $-1.16 | $-1.05 | $-0.86 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $152,967 | $152,715 |
| Low | $152,967 | $152,715 |
| High | $152,967 | $152,715 |
| EBITDA Avg | $-152,967 | $-152,715 |
| Low | $-152,967 | $-152,715 |
| High | $-152,967 | $-152,715 |
| EBIT Avg | $-152,967 | $-152,715 |
| Low | $-152,967 | $-152,715 |
| High | $-152,967 | $-152,715 |
| Net Income Avg | $-6M | $-6M |
| Low | $-6M | $-6M |
| High | $-6M | $-6M |
| EPS Avg | $-0.36 | $-0.36 |
| Low | $-0.36 | $-0.36 |
| High | $-0.36 | $-0.36 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |